Prolactin and Dehydroepiandrosterone Sulfate: Are They Related to the Severity of Chronic Urticaria?.

Archives of Medical Research

Volumn 44, Issue 1, 2013, Pages 21-26

  Kamel Sabry, Mohamed ^a   Nazmy Farres, Mohamed ^a   Abdelnour Melek, Nermine ^a   Ahmed Arafa, Naglaa ^a   Arek Ohanessian, Annie ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b MINISTRY OF HEALTH   (Egypt)

Author keywords

Autoimmune disease; Autologous serum skin test; Chronic urticaria; Dehydroepiandros terone sulfate; Prolactin

Indexed keywords

PRASTERONE SULFATE; PROLACTIN;

ADULT; ARTICLE; AUTOLOGOUS SERUM SKIN TEST; CHRONIC URTICARIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PROLACTIN BLOOD LEVEL; SKIN TEST;

ADULT; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; CHRONIC DISEASE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; PROLACTIN; SKIN TESTS; URTICARIA;

EID: 84873121340     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.10.007     Document Type: Article

References (39)

1. Greaves M. Chronic urticaria. J Allergy Clin Immunol 2000, 105:664-672.
2. Kaplan A.P., Greaves M. Pathogenesis of chronic urticaria. Clin Exp Allergy 2009, 39:777-787.
3. Konstantinou G.N., Asero R., Maurer M., et al. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy 2009, 64:1256-1268.
4. Zuberbier T., Henz B.M., Fiebiger E., et al. Anti-FcepsilonRIalpha serum autoantibodies in different subtypes of urticaria. Allergy 2000, 55:951-954.
5. Caproni M., Volpi W., Giomi B., et al. Chronic idiopathic and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects. Acta Derm Venereol 2004, 84:288-290.
6. Asero R., Orsatti A., Tedeschi A., et al. Autoimmune chronic urticaria associated with type 1 diabetes and Graves' disease. J Allergy Clin Immunol 2005, 115:1088-1089.
7. De Swerdt A., Van Den Keybus C., Kasran A., et al. Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD 63. J Allergy Clin Immunol 2005, 116:662-667.
8. De Bellis A., Bizzarro A., Pivonello R., et al. Prolactin and autoimmunity. Pituitary 2005, 8:25-30.
9. Orbach H., Shoenfeld Y. Hyperprolactinemia and autoimmune diseases. Autoimmun Rev 2007, 6:537-542.
10. Chuang E., Molitch M.E. Prolactin and autoimmune diseases in humans. Acta Biomed 2007, 78(suppl 1):255-261.
11. Kasperska-Zajac A. Does dehydroepiandrosterone influence the expression of urticaria?-a mini review. Inflammation 2011, 34:362-366.
12. Barry N.N., McGuire J.L., van Vollenhoven R.F. Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response. J Rheumatol 1998, 25:2352-2356.
13. Tagawa N., Tamanaka J., Fujinami A., et al. Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism. Clin Chem 2000, 46:523-528.
14. Dillon J.S. Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders. Curr Drug Targets Inflamm Allergy 2005, 4:377-385.
15. Greaves M.W. Chronic urticaria. N Engl J Med 1995, 332:1767-1772.
16. Zuberbier T., Asero R., Bindslev-Jensen C., et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009, 64:1427-1443.
17. Sabroe R.A., Fiebiger E., Francis D.M., et al. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 2002, 110:492-499.
18. Sabroe R.A., Grattan C.E., Francis D.M., et al. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999, 140:446-452.
19. Brzoza Z., Kasperska-Zajac A., Rogala B. Serum prolactin concentration and its relationship with dehydroepiandrosterone sulfate concentration in chronic urticaria patients with positive and negative response to autologous serum skin test. Allergy 2007, 62:566-567.
20. Jara L.J., Medina G., Saavedra M.A., et al. Prolactin and autoimmunity. Clin Rev Allergy Immunol 2011, 40:50-59.
21. Jara L.J., Lavalle C., Fraga A., et al. Prolactin, immunoregulation, and autoimmune diseases. Semin Arthritis Rheum 1991, 20:273-284.
22. McMurray R.W., May W. Sex hormones and systemic lupus erythematosus: review and meta-analysis. Arthritis Rheum 2003, 48:2100-2110.
23. Rezaieyazdi Z., Hesamifard A. Correlation between serum prolactin levels and lupus activity. Rheumatol Int 2006, 26:1036-1039.
24. Fojtíková M., Tomasová Studýnková J., Filková M., et al. Elevated prolactin levels in patients with rheumatoid arthritis: association with disease activity and structural damage. Clin Exp Rheumatol 2010, 28:849-854.
25. Maurer M., Weller K., Bindslev-Jensen C., et al. Unmet clinical needs in chronic spontaneous urticaria. A GA^2LEN task force report. Allergy 2011, 66:317-330.
26. Sabroe R.A., Seed P.T., Francis D.M., et al. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Am Acad Dermatol 1999, 40:443-450.
27. Kulthanan K., Jiamton S., Thumpimukvatana N., et al. Chronic idiopathic urticaria: prevalence and clinical course. J Dermatol 2007, 34:294-301.
28. Metz M., Giménez-Arnau A., Borzova E., et al. Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria. J Allergy Clin Immunol 2009, 123:705-706.
29. Kasperska-Zajac A., Brzoza Z., Rogala B. Serum concentration of dehydroepiandrosterone sulphate in female patients with chronic idiopathic urticaria. J Dermatol Sci 2006, 41:80-81.
30. Kasperska-Zajac A., Brzoza Z., Rogala B. Lower serum concentration of dehydroepiandrosterone sulphate in patients suffering from chronic idiopathic urticaria. Allergy 2006, 61:1489-1490.
31. Kasperska-Zajac A., Brzoza Z., Rogala B. Circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in women suffering from chronic idiopathic urticaria in relation to their pre- or post-menopausal status. Maturitas 2007, 58:211-215.
32. Chen W., Mempel M., Schober W., et al. Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy 2008, 63:1418-1427.
33. Sudo N., Yu X.N., Kubo C. Dehydroepiandrosterone attenuates the spontaneous elevation of serum IgE level in NC/Nga mice. Immunol Lett 2001, 79:177-179.
34. Yu C.K., Liu Y.H., Chen C.L. Dehydroepiandrosterone attenuates allergic airway inflammation in Dermatophagoides farinae-sensitized mice. J Microbiol Immunol Infect 2002, 35:199-202.
35. Altman R., Motton D.D., Kota R.S., et al. Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: roles of PPARalpha and NF-kappaB. Vascul Pharmacol 2008, 48:76-84.
36. Lee K.H., Kim J.Y., Kang D.S., et al. Increased expression of endothelial cell adhesion molecules due to mediator release from human foreskin mast cells stimulated by autoantibodies in chronic urticaria sera. J Invest Dermatol 2002, 118:658-663.
37. Brzoza Z., Kasperska-Zajac A., Badura-Brzoza K., et al. Decline in dehydroepiandrosterone sulfate observed in chronic urticaria is associated with psychological distress. Psychosom Med 2008, 70:723-728.
38. Straub R.H., Schuld A., Mullington J., et al. The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects. J Endocrinol 2002, 175:467-474.
39. Straub R.H., Zeuner M., Lock G., et al. High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis. Br J Rheumatol 1997, 36:426-432.